Mirlacher M - Search Results

1

KIT (CD117)-positive breast cancers are infrequent and lack KIT gene mutations.

Simon R, Panussis S, Maurer R, Spichtin H, Glatz K, Tapia C, Mirlacher M, Rufle A, Torhorst J, Sauter G. Simon R, et al. Among authors: mirlacher m. Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):178-83. doi: 10.1158/1078-0432.ccr-0597-3. Clin Cancer Res. 2004. PMID: 14734467

2

Sequence analysis and high-throughput immunohistochemical profiling of KIT (CD 117) expression in uveal melanoma using tissue microarrays.

Pache M, Glatz K, Bösch D, Dirnhofer S, Mirlacher M, Simon R, Schraml P, Rufle A, Flammer J, Sauter G, Meyer P. Pache M, et al. Among authors: mirlacher m. Virchows Arch. 2003 Dec;443(6):741-4. doi: 10.1007/s00428-003-0883-2. Epub 2003 Sep 26. Virchows Arch. 2003. PMID: 14513377

3

Prevalence of KIT expression in human tumors.

Went PT, Dirnhofer S, Bundi M, Mirlacher M, Schraml P, Mangialaio S, Dimitrijevic S, Kononen J, Lugli A, Simon R, Sauter G. Went PT, et al. Among authors: mirlacher m. J Clin Oncol. 2004 Nov 15;22(22):4514-22. doi: 10.1200/JCO.2004.10.125. J Clin Oncol. 2004. PMID: 15542802

4

Prognostic relevance of gene amplifications and coamplifications in breast cancer.

Al-Kuraya K, Schraml P, Torhorst J, Tapia C, Zaharieva B, Novotny H, Spichtin H, Maurer R, Mirlacher M, Köchli O, Zuber M, Dieterich H, Mross F, Wilber K, Simon R, Sauter G. Al-Kuraya K, et al. Among authors: mirlacher m. Cancer Res. 2004 Dec 1;64(23):8534-40. doi: 10.1158/0008-5472.CAN-04-1945. Cancer Res. 2004. PMID: 15574759

5

EphB2 expression across 138 human tumor types in a tissue microarray: high levels of expression in gastrointestinal cancers.

Lugli A, Spichtin H, Maurer R, Mirlacher M, Kiefer J, Huusko P, Azorsa D, Terracciano L, Sauter G, Kallioniemi OP, Mousses S, Tornillo L. Lugli A, et al. Among authors: mirlacher m. Clin Cancer Res. 2005 Sep 15;11(18):6450-8. doi: 10.1158/1078-0432.CCR-04-2458. Clin Cancer Res. 2005. PMID: 16166419

6

Tissue microarrays for comparing molecular features with proliferation activity in breast cancer.

Ruiz C, Seibt S, Al Kuraya K, Siraj AK, Mirlacher M, Schraml P, Maurer R, Spichtin H, Torhorst J, Popovska S, Simon R, Sauter G. Ruiz C, et al. Among authors: mirlacher m. Int J Cancer. 2006 May 1;118(9):2190-4. doi: 10.1002/ijc.21581. Int J Cancer. 2006. PMID: 16331604

7

Tissue microarrays in cancer diagnosis.

Simon R, Mirlacher M, Sauter G. Simon R, et al. Among authors: mirlacher m. Expert Rev Mol Diagn. 2003 Jul;3(4):421-30. doi: 10.1586/14737159.3.4.421. Expert Rev Mol Diagn. 2003. PMID: 12877382 Review.

8

Tissue microarrays.

Simon R, Mirlacher M, Sauter G. Simon R, et al. Among authors: mirlacher m. Biotechniques. 2004 Jan;36(1):98-105. doi: 10.2144/04361RV01. Biotechniques. 2004. PMID: 14740491 Free article. Review.

9

Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma.

Struckmann K, Schraml P, Simon R, Elmenhorst K, Mirlacher M, Kononen J, Moch H. Struckmann K, et al. Among authors: mirlacher m. Cancer Res. 2004 Mar 1;64(5):1632-8. doi: 10.1158/0008-5472.can-03-1687. Cancer Res. 2004. PMID: 14996721

10

Tissue microarrays.

Simon R, Mirlacher M, Sauter G. Simon R, et al. Among authors: mirlacher m. Methods Mol Med. 2004;97:377-89. doi: 10.1385/1-59259-760-2:377. Methods Mol Med. 2004. PMID: 15064506 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters